Jakavi 20mg -60s (Ruxolitinib Tablet) 20mg

Jakavi 20mg tablets contain ruxolitinib, a prescription medication used for certain blood disorders. This 60-tablet pack is stored at room temperature and supports immune response regulation. Commonly prescribed for myelofibrosis and polycythemia vera, it helps manage symptoms like enlarged spleen. Always follow healthcare provider guidance when using ruxolitinib.

Strength

20mg

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

Novartis Pharma Stein AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ruxolitinib, the active ingredient in Jakavi 20mg tablets, is used to treat myelofibrosis and polycythemia vera, conditions affecting the bone marrow and blood. It helps reduce symptoms such as an enlarged spleen, fatigue, and night sweats by targeting specific pathways in the immune system. This medication is prescribed when other treatments are not suitable or effective. Patients often ask 'what is ruxolitinib used for' to understand its role in managing chronic conditions.

Side Effects

Jakavi 20mg tablets work by influencing the immune system to reduce inflammation and abnormal cell growth in the bone marrow. Users may notice improvements in energy levels and a reduction in spleen size over time. Common effects include mild nausea or dizziness, especially when starting treatment. These effects vary by individual and should be discussed with a healthcare provider.

Precautions & Warnings

Store Jakavi 20mg tablets at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Avoid handling broken or crushed tablets to prevent skin contact with the active ingredient. Always inform your healthcare provider about all medications and supplements you are taking before starting ruxolitinib.

Avoid Interactions

Ruxolitinib may interact with other drugs that affect liver enzymes, such as certain antifungals or antibiotics. Grapefruit products can increase ruxolitinib levels in the blood, so avoid consuming them while taking this medication. Alcohol use should be limited, as it may worsen side effects like dizziness. Always consult a healthcare provider before combining ruxolitinib with other treatments.

Frequently Asked Questions

Ruxolitinib is used to treat myelofibrosis and polycythemia vera, conditions that affect the bone marrow and blood.

Store Jakavi 20mg tablets at room temperature in a dry place, away from direct light and moisture.

It is advisable to limit alcohol use while taking ruxolitinib, as it may increase the risk of side effects like dizziness.

If you miss a dose, take it as soon as you remember unless it is almost time for your next dose; skip the missed dose and resume your regular schedule.

Avoid grapefruit and grapefruit juice, as they can increase the levels of ruxolitinib in your blood.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.